Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is anyone at Acropolis thinking or working on LLBO becoming PinkCurrent. Anyone worried?
i hope something will happen eventually....Hope & praying that's all we have
Over 2 months since release from courts(7/2/24).Not a Sound as to what is going on. Is this legal to do this to Shareholders after Promising in Court at Custodianship Hearing that Shareholders were their top Priority. So far, they have Lied to Shareholders.
Groveman1, then again I think he posted something about Trump and StockRunners replied to that post…because it looks like Bernardis follows StockRunbers on X and viceversa….
Groveman1… that’s interesting… Matt Bernardis was the CEO and President at Cyrcadia Health….. I wonder if they’re still trying to do something with them due to the fact that LLBO made a deal with the iTBra’s patents with them long ago…
Lucky, StockRunners on Twitter had a strange new Tweet about a name from the past (Bernades). Wasn't that Holmes' son in law? Have a Look.
Arnie, Try giving Caren an Email. Maybe she will answer if she gets enough inquiries about LLBO.
G: I sent an email to Joe C. But no reply! I still feel that Caren C. is working on the completion of the Woman testing with Cyrcadia and then submit it to FDA for approval!! In conjunction C. Is also working with Sensoria on the Merger!! That is why it will take a little bit longer than we anticipated!! I do strongly feel that is what's happening!! Just be patient and keep on praying!!
G: I sent an email to Joe C. But no reply! I still feel that Caren C. is working on the completion of the Woman testing with Cyrcadia and then submit it to FDA for approval!! In conjunction C. Is also working with Sensoria on the Merger!! That is why it will take a little bit longer than we anticipated!! I do strongly feel that is what's happening!! Just be patient and keep on praying!!
Arnie ,Has anyone tried Emailing Caren Currier, except me?
Luckyyu: Thank you for trying !! Take Care!
Arnie1, I’ve sent messages but no answer. The only posts/responses are when there is something new to report.
Luckyyu: have you touch bases with Stock Runners lately??
Lucky, I Found Email for Caren Currier. I Emailed her a few days ago and no response at all. Email is carenlarsen@hotmail.com >>>> Why wouldn't or why can't she even give a small response of Recognition. Very odd the way LLBO is being handled. Maybe she will respond to you or Arnie.
Arnie1… me too!!!
I am hoping this year!! Let's keep on praying!!
I hope your right...when about you think this will be....
I agree strongly!! IMO Acropolis is delaying the release of the 10 filings until the following will happen:1 completion of the Woman testing and filings for the FDA approval!! 2. Mergers with Sensoria!! When all these things happened then Acropolis will release the 10 filings!! Followed by Pink Current and Trading!! And then the PPS will Rocket up!!
I agree… but I have reasons to believe the reason is a positive one, not a negative one. I’m sure we will hear something real soon. Frustrating it is… but hopefully we’ll hear soon.
Don't they realize there are Shareholders, and maybe give a short message as to what is Happening. That is not asking a lot from them. Unfortunately, I believe they are being Silent for a Reason. Hope I am Wrong.
There has to be someone else… but that law firm was only for tte custodianship which was already dismissed.
Then how can Acropolis excist without an Email Address or Phone number? Also Caren Currier has disappeared off the face of the Earth. Who is actually doing the Work on LLBO to make it PinkCurrent. It sounded in Court like the Lawyers would be doing the Paperwork to get to PinkCurrent.
They were already dismissed and don’t know anything except for the custodianship.
ok, let us know what they have to say
Dspetry, I just looked up the Attorney's phone number that did paperwork for the Custodianship of LLBO. It was The Law Firm of Mushkin and Coppedge.>>>>>>>>>>>>>>>>>> The Phone # is (702) 454-3333 I believe Mr. Coppedge did the paperwork on LLBO.
Dspetry. Any ideas why an Audit of a Company with no Assets could take this long. Wonder why Acropolis and Currier are dragging their feet to get LLBO PinkCurrent. Do you know of any way to Contact them? Why so silent?
Ask at .0011
anything going to start here?
Luckyyu! This is a positive moves of the pps! I am hoping some good news soon !! Let's keep on praying!!
Arnie1, I agree but most of the world can’t buy right now… very few can… if we could all buy, it wouldn’t be this low already!
IMO .0009 is very low price for this stock to buy!!
Arnie1… I agree with your analogy! Me too ….
G: I am not worried at all!! Frustrated a little bit; yes! In the end we will be a Multi-Millionaire!! Just be " Patient" and kept on Praying!! Enjoy Life and stop worrying!! Okay!!
Arnie, I have been worried for awhile now because of the SLOW way Acropolis is handling LLBO to get it trading. Are you or anyone else starting to worry a little about the slow pace of this. It has been Years, not months or days that this has been going on. Even you have to be a little worried. Does Acropolis really Excist? It has no Email,Twitter, or Phone Numbers. That's a Little ODD, Yes or No?.
Arnie1: Will do, thank you.
Little Pu: Very good that you are in contact with the proper authority!! I will be glad to hear the verdict !!
Arnie1: In Europe we do have the same restrictons...only possible to sell. And I'm already in contact with the Dutch Financial Services Complaints Board on this situation.
Little Pu; if you buy it back it probably will costs more since this stock is hard to get by! In the U.S., you can't buy it but you can only sell!! It seems that majority is holfing this stocks because of its potential to go up rapidly when it's starts Trading again!! In Europe, there is no restrictions! Isn't it? Did you let your Broker know about the situations that they sold your shares without your knowledge?
Thank you Arnie1! Unfortunately I have no more shares left in LLBO. You know if possible at all to buy back again at this moment?
Thank you ! I suggest you should convert your remaining shares to a stock certificate! To prevent from happening again !!
It’s the ‘Saxo Bank’ from the Netherlands. as I’m Dutch.
What broker did sell your shares! It happened to me that is why I had to put mine in the form of certificate !! Mine was Ameritrade before it was part of Schawb!! I have to spent $500.00 for the remaining shares!! Which is worth!!
These shares were mine. My broker did sell them without my permission 😠 Do you know how to buy them back? Thanks
Welcome to Lifeline Biotechnologies Inc. (LLBO) Board!!!
Clinical Trial
In Progress - To Be Completed
** Funding for Clinical Trial
** Vendor delivery of testing materials
Completed for Clinical Trial
** Protocol for testing accepted
** Internal Review Board (IRB) approved
** Contract with hospital executed
Prospective Partner
** Stanford University's Canary Research
Research in blood genomics
The Mastascope is an ultraslim, hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast. Because many cancers actually begin within an individual milk duct, these intraductal tumors are visualized easily and can be biopsied. This product has been used in leading breast centers in the United Kingdom and other countries with great success. Lifeline has obtained a CE mark for marketing and distribution in Europe.
Lifeline has developed and tested an ultraslim endoscope to directly visualize the ovarian surface in the search for cancer. This is of great advantage to physicians, because neither MRI, X-Ray nor Ultrasonography can provide accurate assessments of subtle surface changes. Initial reports of clinical usage have been encouraging.
About $LLBO - Lifeline Biotechnologies, Inc.
About Lifeline Biotechnologies:
Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV. LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer. Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded.
Safe Harbor:
This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.
http://www.firstwarningsystems.com/ became Cyrcadia Health http://cyrcadiahealth.com/
http://www.lbti.com
$LLBO is Cyrcadia's largest shareholder at approximately 40%.
Transfer Agent
OTC Corporate Transfer Service Co.
52 Maple Run Drive
Jericho, NY 11753
Shares Outstanding | 3,026,680,967 | a/o Sep 30, 2014 |
Float | 650,000,000 | a/o Jun 30, 2009 |
Authorized Shares | 4,950,000,000 | a/o Sep 30, 2014 |
Par Value | 0.001 |
About Lifeline Biotechnologies:
Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV. LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer. Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. http://www.lbti.com
Cyrcadia Health founded in 2008, is based in Reno, Nev. The Cyrcadia Health product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO). Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets. See Cyrcadia Health video, “Breast Cancer Tumor Progression” at http://www.cyrcadiahealth.com/
iTBra in the News
ABC 7 News - February 5, 2015
They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.
https://mobile.twitter.com/RobRoyea/status/564872820635627520
Could a Bra Actually Detect Breast Cancer?
By Smithsonian Magzine
http://www.smithsonianmag.com/innovation/could-a-bra-actually-detect-breast-cancer-180954612/?utm_source=twitter.com&no-ist
...Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.
It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU.
Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.
They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |